Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Trading Statement

7 Mar 2005 07:02

Plant Health Care PLC07 March 2005 Press Release For immediate release: 7 March 2005 Plant Health Care plc Trading Statement Plant Health Care plc ("PHC" or the "Company"), the leading supplier of naturalproducts for plants and soil, provides an update on current trading. Sales for the year ended 31 December 2004 for the US, PHC Mexico, PHCNetherlands and PHC Reclamation were in line with expectations. We had expectedthe UK operation to be achieving further sales into the Spanish market, whichwas already penetrated through sales of PHC's Liquid Organic Plant Food, and theopening of a Spanish office. However, the UK division was unable to accelerateits Spanish sales due to the slow response of the Spanish government in issuingthe business registration permit. Additionally, a key supplier was late ondelivery of products because of labeling issues during the key part of theseason and sales were missed. As a consequence, sales for this business unitwill be below target. The Spanish company has now been formed and awarded itstax number and labeling issues have been resolved. We also accelerated our distributor early order programme from the first quarterof 2005 into the fourth quarter of 2004. This change, which aligned the companywith standard industry practices in the US landscape market, neverthelesscontributed to a deterioration of percentage margins because of the pricing onlarge orders. It is anticipated that margins in 2005 will return to previouslevels due to already implemented price increases combined with the operatingefficiencies that will be realized by the new manufacturing plant. The Company has been evaluating the prospect of relocating its Pittsburghmanufacturing plant for some time. The Directors recently received notificationthat a potential tenant is willing to lease a significant portion of the spacewhich would allow PHC an economical exit from the property. The proceedsreceived from the AIM IPO allow PHC to sublet the current plant and take a onetime charge in 2004. Accordingly, the Board has decided to take advantage ofthis opportunity and relocate the Pittsburgh manufacturing plant to a newsignificantly lower cost site. Whilst there will be a one off restructuring andrelocation charge, the new manufacturing facility is expected to reduce rentalcosts by approximately 50% and realise operating efficiencies through bettermachinery layout and more advanced equipment. We estimate that payback on theinvestment by way of cost savings will be achieved in less then 2 years. The Company has decided to accelerate the entry of its Myconate seed coatingproduct, acquired from VAMTech in October 2004, into the European market and asa consequence incurred costs that were originally budgeted for 2005. On thestrength of the Myconate test results announced in early December, and theinterest for the product by some key European distributors, management electedto commission a study of key European corn and wheat growing regions to targetthe markets which will provide optimal entry points for the product's Europeanlaunch. This combined with the earlier than expected recruitment costs for aseed coating General Manager moved expenses into the fourth quarter of 2004rather than in 2005 as anticipated. The management also decided to accelerate the hiring of several other keyindividuals to drive the growth of the Company. A General Manager for the USoperation was added along with several sales people to extend coverage moreuniformly across the US. Whilst the Directors believe the relocation of the manufacturing facility andthe acceleration of the move of the seed coating business into Europe willgreatly benefit the business these moves, together with the other mattersreferred to above, will cause the losses in 2004 to be some $1,100,000 greaterthan previously expected. The underlying trends for the business are stronger than ever and, coupled withthe added coverage by the new sales hires, the Directors expect current growthto continue in the coming months and into the future. For further information please contact: Plant Health Care plc Tavistock CommunicationsJohn Brady, CEO Jeremy Carey/Katy PrattTel: 001 603 525 3702 Tel: 020 7920 3150Steve Whitcomb Email: kpratt@tavistock.co.ukTel: 001 412 826 5488 Notes to Editors About PHC Plant Health Care plc ("PHC") is a leading provider of natural products forplants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the UnitedStates, PHC currently has approximately 60 employees and has operations in theUS, Mexico, UK and the Netherlands with technical support in Austria. The Grouphas two principal operating subsidiaries in the US - PHC Inc (PA) and PHCReclamation. The Company listed on the AIM market of the London Stock Exchangein July 2004. PHC's products are aimed at the horticulture, agriculture, turf grass,commercial landscaping, forestry and land reclamation industries and are bothenvironmentally beneficial and on the whole more cost effective than syntheticchemical alternatives. Through the commercialisation of these products, PHC iscapitalising on current long-term trends toward natural systems and biologicalproducts for plant care and soil and water management uses. PHC Reclamation is an environmental and reclamation engineering consulting firmproviding cost effective, biologically based solutions for the reclamation andrestoration of lands disturbed by mining, construction and other activities. PHCReclamation was established in 1997 to exploit PHC's products and technology. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Nov 20193:56 pmRNSHolding(s) in Company
6th Nov 201912:57 pmRNSInvestment in Company by Ospraie Ag Science LLC
30th Oct 20197:00 amRNSAppointment of new Board Directors
3rd Oct 20192:50 pmRNSDirector/PDMR Shareholding
30th Sep 20197:00 amRNSInterim Report ended 30 June 2019
9th Sep 20197:00 amRNSPilot production of PREtec peptides
19th Aug 20197:00 amRNSBlock listing Interim Review
15th Aug 20197:00 amRNSProgress with PREtec field trials in Brazil
5th Aug 20195:18 pmRNSHolding(s) in Company
25th Jun 20197:00 amRNSNew Distribution Agreement with Wilbur-Ellis
12th Jun 201911:05 amRNSResult of AGM
30th Apr 20194:19 pmRNSAnnual Report & Accounts and AGM Notice Published
10th Apr 20197:00 amRNSResults for the year ended 31 December 2018
27th Mar 20193:41 pmRNSHolding(s) in Company
28th Feb 20197:00 amRNSNew Technology Update
19th Feb 20197:00 amRNSBlock listing Interim Review
29th Jan 20197:00 amRNSTrading Statement
24th Jan 20195:58 pmRNSHolding(s) in Company
21st Dec 20187:00 amRNSTrading Statement
28th Nov 20187:00 amRNSNew Technology Update
21st Nov 20187:00 amRNSPlant Health Care ProAct® Wins Top Industry Award
19th Nov 20187:00 amRNSPlant Health Care to present at Mello London
14th Nov 20187:00 amRNSPositive Developments with Harpin
8th Nov 20187:00 amRNSChange of Adviser
5th Nov 20187:00 amRNSHolding(s) in Company
18th Sep 20187:00 amRNSInterim Report ended 30 June 2018
12th Sep 20187:00 amRNSUS Announces Harpin aß Product Launch in Corn
20th Aug 20187:00 amRNSBlock listing Interim Review
30th Jul 20187:00 amRNSUpdate on sugarcane in Brazil
16th Jul 20187:00 amRNSTrading Statement
6th Jun 20182:39 pmRNSHolding(s) in Company
6th Jun 201811:14 amRNSResult of AGM
30th May 20187:00 amRNSGrant of Options
4th May 20185:59 pmRNSHolding(s) in Company
30th Apr 20183:11 pmRNSPublication of Annual Report and Notice of AGM
10th Apr 20187:00 amRNSResults for the year ended 31 December 2017
8th Mar 20187:00 amRNSBlock listing Interim Review
7th Mar 20183:07 pmRNSHolding(s) in Company
7th Mar 20183:06 pmRNSHolding(s) in Company
7th Mar 20183:02 pmRNSHolding(s) in Company
2nd Mar 20185:48 pmRNSHolding(s) in Company
27th Feb 20184:12 pmRNSResult of Placing and Subscription
27th Feb 20187:00 amRNSProposed Placing and Subscription
24th Jan 20187:00 amRNSTrading Statement
12th Dec 20177:00 amRNSNew Technology Update
8th Dec 20174:35 pmRNSPrice Monitoring Extension
6th Dec 20174:40 pmRNSSecond Price Monitoring Extn
6th Dec 20174:35 pmRNSPrice Monitoring Extension
18th Sep 20177:00 amRNSHalf-year Report
21st Aug 20177:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.